Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Bioscience symbols : Nbix save search
Neurocrine Biosciences to Present at Stifel 2022 CNS Days
Published: 2022-03-21 (Crawled : 00:00) - biospace.com/
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
|
| O: -0.03%
H: 1.33%
C: 1.14%
bioscience
Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2021 Financial Results and Provides Financial Expectations for Fiscal 2022
Published: 2022-02-11 (Crawled : 13:00) - prnewswire.com
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: 0.0%
financial results ces report bioscience results
Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2021 Financial Results
Published: 2022-01-25 (Crawled : 22:00) - biospace.com/
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
|
| O: -1.45%
H: 2.57%
C: 1.57%
financial results conference bioscience
Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $15.0 Million Regulatory Milestone
Published: 2022-01-12 (Crawled : 14:00) - biospace.com/
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: 3.38%
H: 0.31%
C: -4.18%
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
|
| O: -0.79%
H: 3.15%
C: 1.82%
milestone bioscience collaboration
Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2021 Net Product Sales Results and Future Program Milestones
Published: 2022-01-06 (Crawled : 00:00) - biospace.com/
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: 2.64%
H: 0.0%
C: -0.39%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: -0.99%
H: 0.0%
C: -1.16%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 1.0%
H: 0.0%
C: 0.0%
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
sales bioscience milestone
Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
Published: 2021-12-23 (Crawled : 23:00) - globenewswire.com
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
| Email alert
Add to watchlist
clearance license trust bioscience
Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine for Chorea Associated with Huntington Disease
Published: 2021-12-07 (Crawled : 00:00) - biospace.com/
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
|
| O: 0.61%
H: 0.0%
C: 0.0%
huntington disease positive bioscience phase 3 huntington’s disease
Neurocrine Biosciences Presents New INGREZZA® (valbenazine) Data at Psych Congress 2021
Published: 2021-11-01 (Crawled : 15:00) - biospace.com/
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: -0.13%
H: 1.18%
C: 1.18%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: -0.11%
H: 0.94%
C: 0.94%
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
|
| O: 0.09%
H: 2.38%
C: 0.68%
bioscience
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2021 Financial Results
Published: 2021-10-11 (Crawled : 20:00) - prnewswire.com
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
|
| O: 0.31%
H: 2.85%
C: 0.69%
financial results results conference bioscience
Neurocrine Biosciences Reports Second Quarter 2021 Financial Results
Published: 2021-08-03 (Crawled : 22:00) - biospace.com/
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
|
| O: -0.14%
H: 2.53%
C: 2.0%
financial results results bioscience
Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2021 Financial Results
Published: 2021-07-19 (Crawled : 21:00) - biospace.com/
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
|
| O: -0.09%
H: 0.27%
C: -1.21%
financial results results conference bioscience
Neurocrine Biosciences Supports Mental Health Month and Tardive Dyskinesia Awareness Week
Published: 2021-05-03 (Crawled : 13:00) - biospace.com/
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
|
| O: 0.4%
H: 1.18%
C: -1.31%
skin health bioscience
Neurocrine Biosciences Announces Appointment of Johanna Mercier to Board of Directors
Published: 2021-04-16 (Crawled : 13:15) - prnewswire.com
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
|
| O: 1.49%
H: 0.52%
C: 0.17%
bioscience
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2021 Financial Results
Published: 2021-04-14 (Crawled : 00:00) - biospace.com/
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
|
| O: 0.32%
H: 3.99%
C: 1.91%
financial results results conference bioscience
Neurocrine Biosciences to Present at Stifel 3rd Annual CNS Day
Published: 2021-03-25 (Crawled : 22:00) - biospace.com/
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
|
| O: 7.67%
H: 4.97%
C: 3.15%
presentation bioscience
Neurocrine Biosciences to Present at the Oppenheimer 31st Annual Healthcare Conference
Published: 2021-03-09 (Crawled : 23:02) - biospace.com/
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
|
| O: 1.6%
H: 2.75%
C: 0.23%
bioscience
Neurocrine Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results
Published: 2021-02-04 (Crawled : 21:08) - prnewswire.com
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
|
| O: -0.65%
H: 4.53%
C: 2.06%
results financial results bioscience
Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2020 Financial Results
Published: 2021-01-20 (Crawled : 23:00) - biospace.com/
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
|
| O: 0.11%
H: 2.62%
C: 2.0%
results bioscience
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.